Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masashi Ando

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
Investigational New Drugs|April 4, 2014
Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcomaTakafumi Ueda, Shigeki Kakunaga, Masashi Ando, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Genetic testing for effective Herceptin therapy]Toru Watanabe, Noriyuki Katsumata, Masashi Ando, et al.
Plos One|February 3, 2012
Immunohistochemical profile for unknown primary adenocarcinomaKenji Hashimoto, Yuko Sasajima, Masashi Ando, et al.
Anticancer Research|November 29, 2023
Peptide Receptor Radionuclide Therapy for Recurrent Olfactory Neuroblastoma After Cranioplasty for Surgical Infection: A Case ReportHidenori Suzuki, Shoichi Haimoto, Yoshitaka Inaba, et al.
Japanese Journal of Clinical Oncology|May 30, 2009
Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancerChikako Shimizu, Norikazu Masuda, Kenichi Yoshimura, et al.
Journal of Molecular Histology|April 25, 2012
Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiationTomohiro Itoh, Yuko Ito, Yoshinori Ohtsuki, et al.
Cancer Science|October 27, 2025
Realizing Equitable Precision Oncology via Remote Participation: Japan's First Fully Decentralized Trial (WJOG15221M)Hiroya Taniguchi, Toshiki Masuishi, Tomoki Sakakida, et al.
The Journal of Antibiotics|November 29, 2021
New dihydronaphthothiophene derivatives by the biological transformation of seriniquinone using marine-derived actinomycete Streptomyces albogriseolus OM27-12Kohei Ishida, Teruki Tanaka, Kenichiro Nagai, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 17, 2018
Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecanChihiro Kondoh, Shigenori Kadowaki, Azusa Komori, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2010
Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapyMaki Tanioka, Noriyuki Katsumata, Kan Yonemori, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Investigational New Drugs|April 4, 2014
Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcomaTakafumi Ueda, Shigeki Kakunaga, Masashi Ando, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Genetic testing for effective Herceptin therapy]Toru Watanabe, Noriyuki Katsumata, Masashi Ando, et al.
Plos One|February 3, 2012
Immunohistochemical profile for unknown primary adenocarcinomaKenji Hashimoto, Yuko Sasajima, Masashi Ando, et al.
Anticancer Research|November 29, 2023
Peptide Receptor Radionuclide Therapy for Recurrent Olfactory Neuroblastoma After Cranioplasty for Surgical Infection: A Case ReportHidenori Suzuki, Shoichi Haimoto, Yoshitaka Inaba, et al.
Japanese Journal of Clinical Oncology|May 30, 2009
Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancerChikako Shimizu, Norikazu Masuda, Kenichi Yoshimura, et al.
Journal of Molecular Histology|April 25, 2012
Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiationTomohiro Itoh, Yuko Ito, Yoshinori Ohtsuki, et al.
Cancer Science|October 27, 2025
Realizing Equitable Precision Oncology via Remote Participation: Japan's First Fully Decentralized Trial (WJOG15221M)Hiroya Taniguchi, Toshiki Masuishi, Tomoki Sakakida, et al.
The Journal of Antibiotics|November 29, 2021
New dihydronaphthothiophene derivatives by the biological transformation of seriniquinone using marine-derived actinomycete Streptomyces albogriseolus OM27-12Kohei Ishida, Teruki Tanaka, Kenichiro Nagai, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 17, 2018
Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecanChihiro Kondoh, Shigenori Kadowaki, Azusa Komori, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2010
Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapyMaki Tanioka, Noriyuki Katsumata, Kan Yonemori, et al.
Pageof 16